Publication
Estimate of economic impact of immune checkpoint inhibitors for NSCLC relative to PD-L1 expression in the US
dc.contributor.author | Aguiar, Pedro, Jr. | |
dc.contributor.author | De Mello, Ramon Andrade | |
dc.contributor.author | Tadokoro, Hakaru | |
dc.contributor.author | Babiker, Hani | |
dc.contributor.author | Gutierres, Barbara | |
dc.contributor.author | Lopes, Gilberto | |
dc.date.accessioned | 2019-11-20T15:07:59Z | |
dc.date.available | 2019-11-20T15:07:59Z | |
dc.date.issued | 2017-01 | |
dc.identifier.issn | 1556-0864 | |
dc.identifier.issn | 1556-1380 | |
dc.identifier.uri | http://hdl.handle.net/10400.1/13306 | |
dc.language.iso | eng | |
dc.peerreviewed | yes | |
dc.publisher | Elsevier Science Inc | |
dc.title | Estimate of economic impact of immune checkpoint inhibitors for NSCLC relative to PD-L1 expression in the US | |
dc.type | conference object | |
dspace.entity.type | Publication | |
oaire.citation.endPage | S308 | |
oaire.citation.issue | 1 | |
oaire.citation.startPage | S308 | |
oaire.citation.title | Journal of Thoracic Oncology | |
oaire.citation.volume | 12 | |
person.familyName | de Mello | |
person.givenName | Ramon Andrade | |
person.identifier.orcid | 0000-0002-9640-4573 | |
rcaap.rights | restrictedAccess | |
rcaap.type | conferenceObject | |
relation.isAuthorOfPublication | 53ee625f-c5c3-468b-85bb-4cef5ad36928 | |
relation.isAuthorOfPublication.latestForDiscovery | 53ee625f-c5c3-468b-85bb-4cef5ad36928 |
Files
Original bundle
1 - 1 of 1